Dr. Bo Rode Hansen explains why he joined LIfT as a Non-Executive Director
We recently caught up with Dr. Bo Rode Hansen, a Non-Executive Director at LIfT, to find out what motivated him to join LIfT and why he...
top of page
LATEST NEWS
Feb 22
LIfT’s CEO challenges out dated thinking that therapies focused on T-Cells alone are enough to achieve complete remission in most solid tumours
During a presentation at the Biotech Showcase, our CEO, Alex Blyth challenged the current view that T-cells can do it all, highlighting...
Dec 21, 2023
LIfT BioSciences appoints Dr Bo Rode Hansen and Dr Marco Gottardis to its Board of Directors
London, 21st December 2023 – LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech company bringing to market a...
bottom of page